Medicare Enrolled

Dr. Lita Calagua Solis, MD

Neurology · Davie, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
10650 W SR 84, Davie, FL 33324
9544768126
In practice since 2006 (19 years)
NPI: 1932272010 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Calagua Solis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Calagua Solis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Calagua Solis

Dr. Lita Calagua Solis is a neurology in Davie, FL, with 19 years in practice. Based on federal Medicare data, Dr. Calagua Solis performed 58 Medicare services across 52 unique beneficiaries.

Between the years covered by Open Payments, Dr. Calagua Solis received a total of $8,941 from 50 pharmaceutical and/or device companies across 484 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Calagua Solis is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 58 Medicare services$ $8,941 industry payments

Medicare Practice Summary

Medicare Utilization ↗
58
Medicare services
Bottom 5% in FL for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
52
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
New patient office visit (45-59 min)31$117$275
Office visit, established patient (30-39 min)27$93$200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,941
Total received (2018-2024)
Avg $1,277/year across 7 years
Top 30% in FL for neurology
50
Companies
484
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,882 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$59 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,608
2023
$1,971
2022
$1,579
2021
$1,335
2020
$980
2019
$997
2018
$471

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$1,133
Lilly USA, LLC
$799
Amneal Pharmaceuticals LLC
$687
EMD Serono, Inc.
$470
AbbVie Inc.
$467
Teva Pharmaceuticals USA, Inc.
$422
Sunovion Pharmaceuticals Inc.
$406
ABBVIE INC.
$322
SK Life Science, Inc.
$287
Novartis Pharmaceuticals Corporation
$265
Biohaven Pharmaceuticals, Inc.
$259
Otsuka America Pharmaceutical, Inc.
$253
Amgen Inc.
$220
GENZYME CORPORATION
$206
Eisai Inc.
$198
Neurelis, Inc.
$169
MITSUBISHI TANABE PHARMA AMERICA, INC.
$166
ARGENX US, INC.
$163
Sumitomo Pharma America, Inc.
$140
Upsher-Smith Laboratories LLC
$135
Adamas Pharmaceuticals, Inc.
$133
EISAI INC.
$129
Biogen, Inc.
$123
Acorda Therapeutics, Inc
$122
Supernus Pharmaceuticals, Inc.
$104
Janssen Pharmaceuticals, Inc
$103
ACADIA Pharmaceuticals Inc
$99
Lundbeck LLC
$96
PFIZER INC.
$88
Avion Pharmaceuticals
$87
Kyowa Kirin, Inc.
$77
Allergan, Inc.
$76
Alexion Pharmaceuticals, Inc.
$74
Biohaven Pharmaceutical Holding Company Ltd.
$57
IMPEL PHARMACEUTICALS INC.
$45
Avanir Pharmaceuticals, Inc.
$39
Neurocrine Biosciences, Inc.
$37
Mallinckrodt Hospital Products Inc.
$28
Aprecia Pharmaceuticals, LLC
$28
Corium, LLC
$26
Vanda Pharmaceuticals Inc.
$25
BOSTON SCIENTIFIC CORPORATION
$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$22
Mitsubishi Tanabe Pharma America, Inc.
$22
UPSHER-SMITH LABORATORIES LLC
$20
Endo Pharmaceuticals Inc.
$19
Octapharma USA, Inc.
$19
Abbott Laboratories
$18
Impax Laboratories, Inc.
$17
Vertical Pharmaceuticals, LLC
$16
Top 3 companies account for 29.3% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aduhelm · Aimovig · Austedo XR · Briviact · CAPLYTA · COMIRNATY · DIVIGEL · Dhivy · EMGALITY · Fycompa · GENERAL - DBS · GILENYA · GOCOVRI · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LEMTRADA · LEQEMBI · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NASCOBAL · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OXTELLAR XR · PANZYGA · PONVORY · PROCLAIM · Ponvory · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · REYVOW · RYTARY · Radicava · Rebif · SOLIRIS · Soliris · Spritam · TOPIRAMATE Extended Release Capsules · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · VALTOCO · VARITHENA · VRAYLAR · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $15,416 per 100 Medicare services performed
Looking for a neurology in Davie?
Compare neurologys in the Davie area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
298
Per 100K population
15.3
County median income
$74,534
Nearest hospital
WESTSIDE REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Calagua Solis is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Calagua Solis experienced with new patient office visit (45-59 min)?
Based on Medicare claims data, Dr. Calagua Solis performed 31 new patient office visit (45-59 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Calagua Solis receive payments from pharmaceutical companies?
Yes. Dr. Calagua Solis received a total of $8,941 from 50 companies across 484 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Calagua Solis's costs compare to other neurologys in Davie?
Dr. Calagua Solis's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Calagua Solis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →